Cheryl Cohen

Last updated

Cheryl Cohen
Alma mater University of the Witwatersrand
London School of Hygiene & Tropical Medicine
Scientific career
Institutions National Institute for Communicable Diseases
University of the Witwatersrand
Thesis 'Influenza-associated morbidity and mortality in South Africa'  (2014)

Cheryl Cohen is a South African public health researcher who is a professor at the University of the Witwatersrand. She looks to develop evidence-based policy to reduce the burdens of respiratory diseases. During the COVID-19 pandemic. Cohen investigated the rates of COVID-19 in South Africa.

Contents

Early life and education

Cohen was inspired by her mother to pursue a career in medicine. [1] As a child, she accompanied her mother on ward rounds in her local infectious diseases hospital. She eventually studied medicine at the University of the Witwatersrand. [2] She became aware that it was difficult to treat infectious diseases in Africa. In particular, it was difficult in securing antiretroviral medications for the treatment of HIV. [1] [2] She has described working in hospitals at the time as like being in a war zone. [1] She decided that she would have more of an impact working in public health, so earned a MSc in epidemiology at the London School of Hygiene & Tropical Medicine. [2] [3] Her doctoral research considered morbidity and mortality related to influenza in South Africa. [4]

Research and career

Cohen leads the Center for Respiratory Disease and Meningitis at the National Institute for Communicable Diseases. [1] [3] She oversees public health surveillance for respiratory diseases. [1] In 2009, she established a national surveillance programme for respiratory infections. [3] Her work revealed that the disease burden of influenza in South Africa exceeded that of high income countries. She identified that HIV positive individuals have an elevated risk of severe illnesses associated with influenza. She showed that the majority of adults hospitalised with influenza were also infected with HIV. [1]

Cohen found that young children were particularly susceptible to influenza, and recommended that future vaccination programmes focus on this demographic. [1] When the COVID-19 pandemic spread across the world in 2020, Cohen was well prepared for analysing the epidemiology of SARS-CoV-2. [1] [2] She identified that around 85% of COVID infected people were asymptomatic. She also showed that people living with HIV were more likely to suffer from severe forms of COVID-19, and that they were likely to shed SARS-CoV-2 for longer. [1]

Selected publications

Related Research Articles

<span class="mw-page-title-main">Pandemic</span> Global epidemic of infectious disease

A pandemic is an epidemic of an infectious disease that has spread across a large region, for instance multiple continents or worldwide, affecting a substantial number of individuals. A widespread endemic disease with a stable number of infected individuals is not a pandemic. Widespread endemic diseases with a stable number of infected individuals such as recurrences of seasonal influenza are generally excluded as they occur simultaneously in large regions of the globe rather than being spread worldwide.

<span class="mw-page-title-main">Flu season</span> Recurring periods of influenza

Flu season is an annually recurring time period characterized by the prevalence of an outbreak of influenza (flu). The season occurs during the cold half of the year in each hemisphere. It takes approximately two days to show symptoms. Influenza activity can sometimes be predicted and even tracked geographically. While the beginning of major flu activity in each season varies by location, in any specific location these minor epidemics usually take about three weeks to reach its pinnacle, and another three weeks to significantly diminish.

Immunization during pregnancy is the administration of a vaccine to a pregnant individual. This may be done either to protect the individual from disease or to induce an antibody response, such that the antibodies cross the placenta and provide passive immunity to the infant after birth. In many countries, including the US, Canada, UK, Australia and New Zealand, vaccination against influenza, COVID-19 and whooping cough is routinely offered during pregnancy.

Economic epidemiology is a field at the intersection of epidemiology and economics. Its premise is to incorporate incentives for healthy behavior and their attendant behavioral responses into an epidemiological context to better understand how diseases are transmitted. This framework should help improve policy responses to epidemic diseases by giving policymakers and health-care providers clear tools for thinking about how certain actions can influence the spread of disease transmission.

Alison P. Galvani is an American epidemiologist. She is the Burnett and Stender Families Professor of Epidemiology at the Yale School of Public Health and the Director of the Center for Infectious Disease Modeling and Analysis.

<span class="mw-page-title-main">Neil Ferguson (epidemiologist)</span> British epidemiologist and researcher

Neil Morris Ferguson is a British epidemiologist and professor of mathematical biology, who specialises in the patterns of spread of infectious disease in humans and animals. He is the director of the Jameel Institute for Disease and Emergency Analytics (J-IDEA), director of the MRC Centre for Global Infectious Disease Analysis, and head of the Department of Infectious Disease Epidemiology in the School of Public Health and Vice-Dean for Academic Development in the Faculty of Medicine, all at Imperial College London.

<span class="mw-page-title-main">Vaxart</span> American biotechnology company based in San Francisco

Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Its development programs for oral vaccine delivery include prophylactic, enteric-coated tablet vaccines for inhibiting norovirus, seasonal influenza, respiratory syncytial virus, and human papillomavirus. It was founded in 2004 by Sean Tucker.

<span class="mw-page-title-main">Caitlin Rivers</span> American emerging infectious disease epidemiologist

Caitlin M. Rivers is an American epidemiologist who as Senior Scholar at the Johns Hopkins Center for Health Security and assistant professor at the Johns Hopkins Bloomberg School of Public Health, specializing on improving epidemic preparedness. Rivers is currently working on the American response to the COVID-19 pandemic with a focus on the incorporation of infectious disease modeling and forecasting into public health decision making.

<span class="mw-page-title-main">Arnold Monto</span> American physician and epidemiologist

Arnold Monto is an American physician and epidemiologist. At the University of Michigan School of Public Health, Monto is the Thomas Francis Jr. Collegiate Professor of Public Health, professor of epidemiology, and professor of global public health. His research focuses on the occurrence, prevention, and treatment of infectious diseases in industrialized and developing countries' populations.

Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.

Cécile Viboud is a Staff Scientist based in the Fogarty International Center at the National Institutes of Health, where she is part of the Multinational Influenza Seasonal Mortality Study (MISMS). Viboud specialises in the mortality of infectious disease. Viboud was involved with epidemiological analysis during the COVID-19 pandemic.

Kimberly A. Powers is an American epidemiologist who is an associate professor of epidemiology at the UNC Gillings School of Global Public Health. She combines epidemiology, statistics and mathematical modelling to understand the transmission of infectious diseases. In 2011 her work on antiretroviral therapy for the management of human immunodeficiency virus was selected by Science as the breakthrough of the year. During the COVID-19 pandemic, Powers looked to understand the spread of SARS-CoV-2.

Helen Y. Chu is an American immunologist who is an Assistant Professor of Medicine at the University of Washington. Her research considers maternal immunization, with a focus on influenza and respiratory syncytial virus. During the COVID-19 pandemic, Chu was the first physician to recognise community transmission of the coronavirus disease within the United States.

<span class="mw-page-title-main">Impact of the COVID-19 pandemic on other health issues</span> Health consequences of outbreak beyond the COVID-19 disease itself

The COVID-19 pandemic has had many impacts on global health beyond those caused by the COVID-19 disease itself. It has led to a reduction in hospital visits for other reasons. There have been 38 per cent fewer hospital visits for heart attack symptoms in the United States and 40 per cent fewer in Spain. The head of cardiology at the University of Arizona said, "My worry is some of these people are dying at home because they're too scared to go to the hospital." There is also concern that people with strokes and appendicitis are not seeking timely treatment. Shortages of medical supplies have impacted people with various conditions.

Sylvie Champaloux Briand is a French physician who is Director of the Pandemic and Epidemic Diseases Department at the World Health Organization. Briand led the Global Influenza Programme during the 2009 swine flu pandemic. During the COVID-19 pandemic, Briand launched the WHO Information Network for Epidemics which looked to counter the spread of COVID-19 misinformation.

<span class="mw-page-title-main">Yee-Sin Leo</span> Singaporean physician

Yee-Sin Leo is a Singaporean physician. Leo is the executive director of the National Centre for Infectious Diseases and researches emerging infectious diseases. She has been in charge of Singapore's response to several outbreaks, including Nipah, SARS and COVID-19. In 2020, she was selected as one of the BBC's top 100 Women.

<span class="mw-page-title-main">Shabir Madhi</span> South African physician and professor

Shabir Ahmed Madhi is a South African physician who is professor of vaccinology and director of the South African Medical Research Council Respiratory and Meningeal Pathogens Research Unit at the University of the Witwatersrand, and National Research Foundation/Department of Science and Technology Research Chair in Vaccine Preventable Diseases. In January 2021, he was appointed Dean of the Faculty of Health Sciences at the University of the Witwateratand.

Debby Bogaert is a Dutch physician who is Professor of Paediatric Infectious Diseases at the University of Edinburgh. Her research considers the physiology and pathophysiology of respiratory infections.

The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) is an international research initiative based in Oxford, England. It is hosted at the Nuffield Department of Medicine within the University of Oxford and led by the Epidemic diseases Research Group Oxford (ERGO). ISARIC is funded by the Bill & Melinda Gates Foundation, Foreign, Commonwealth and Development Office, and Wellcome Trust.

Marie-Carmelle Elie is an American emergency physician who is Professor and Chair of Emergency Medicine at the University of Alabama at Birmingham. She was elected Fellow of the National Academy of Medicine in 2022.

References

  1. 1 2 3 4 5 6 7 8 9 Kazi, Farooq; Mushtaq, Ammara (1 March 2022). "Cheryl Cohen—promoting evidence-based health policy". The Lancet Infectious Diseases. 22 (3): 325. doi:10.1016/S1473-3099(22)00078-0. ISSN   1473-3099. PMID   35218755. S2CID   247099767.
  2. 1 2 3 4 "Cheryl Cohen: tracking respiratory diseases, informing policy". Bulletin of the World Health Organization. 98 (12): 828–829. 1 December 2020. doi:10.2471/BLT.20.031220. ISSN   0042-9686. PMC   7716097 . PMID   33293742.
  3. 1 2 3 "Cheryl Cohen, Associate Professor, University of the Witwatersrand". isirv.org. Retrieved 20 March 2022.
  4. ↑ Cohen, Cheryl (2014). Influenza-associated morbidity and mortality in South Africa (Thesis). OCLC   911198328.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.